Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome

The goal of this study was to assess the clinical performance of an investigational in vitro fecal calprotectin immunoassay for differentiating inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS). BACKGROUND: Fecal calprotectin is a stool biomarker that can assist in the detection o...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, James P., Zierold, Claudia, Rode, Ashli M., Blocki, Frank A., Vaughn, Byron P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
ALIMENTARY TRACT: Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960147/
https://www.ncbi.nlm.nih.gov/pubmed/32324678
http://dx.doi.org/10.1097/MCG.0000000000001359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960147/
https://www.ncbi.nlm.nih.gov/pubmed/32324678
http://dx.doi.org/10.1097/MCG.0000000000001359

Ejemplares similares